Pfizer’s big fat fail 12/1/23
CNBC's "Fast Money"
00:00
Paramount's Performance and Future Prospects
The speakers analyze Paramount's recent performance and debate whether it's a good investment, considering different timeframes and the potential for a pullback. They also discuss the impact of lack of news and sports on the long-term value proposition.
Play episode from 28:33
Transcript
